Our Mission
We supply the world with active pharmaceutical ingredients, enabling our customers to improve their patients’ quality of life.
Products
Steroids, APIs and more
As part of the PharmaZell Group, Farmabios is the leading global manufacturer of non-sterile and sterile steroids and offers custom development and manufacturing services of focused portfolio of High Potent Substances (HPS) and anticancer drugs. With decades of steroid chemistry expertise and ongoing research and development activities, Farmabios provides a flexible approach that meets the specific requirements of each customer.
Contact our Experts
Our culture of innovation and transparency embraces a continuous improvement of processes. Farmabios experts are here to help you find solutions. Click below to contact them.
Still looking for help?
If you’re still looking for a Generic API or service, please use the icons to contact more experts.
Farmabios is part of the PharmaZell Group. With expertise that spans more than one hundred years, the Group ensures high quality and added value. The Group is committed to innovative, green technologies and a focused product portfolio. Click here to learn more.
Competencies
Our Core Values
At Farmabios, we are continually creating a culture of innovation built on open dialogue, new ideas and flexibility. Our approach enables us to adapt supply chains for optimal quality and for securing product supply. Our guiding principles are captured in our Code of Business Ethics which is built on respect for one another, for our partners and for the environment. We are continuously striving to improve plant processes. We believe that investing in both our plants and our people pays off.
About Us
As part of the PharmaZell Group, Farmabios is the leading global manufacturer of non-sterile and sterile steroids and offers custom development and manufacturing services of a focused portfolio of High Potent Substances (HPS) and anticancer drugs. With decades of steroid chemistry expertise and ongoing research and development activities, Farmabios provides a flexible approach that meets the specific requirements of each customer.
News and Fairs
Acquisition of PharmaZell Group by Bridgepoint completed. PharmaChol fully owned by the PharmaZell Group.
Bridgepoint, an international asset management firm with over €20 billion of assets, announced the acquisition of the PharmaZell Group in February 2020. After obtaining all necessary authorizations, we are very
CURRENT COVID-19 OUTBREAK: SUPPORTIVE HELP
Farmabios is pleased to announce that it has just finalized the production and distribution of sanitizing gels to Covid-19 task forces and structures which are serving the neighboring area, as
UPDATE 4: IMPACT OF THE CURRENT COVID-19 OUTBREAK ON INDIAN PRODUCTION SITES
PharmaZell Group is very conscious of our important role and duty in delivering APIs to our customers and being an active part in maintaining the health system running. Up to
FarmaBios activities are regularly proceeding…
During this critical and challenging period, Farmabios SpA states that our activities are regularly proceeding. We are conscious of the role and duty in delivering APIs, and our active part
Breaking News: PharmaZell Group acquired by Bridgepoint
The PharmaZell Group management is very pleased to inform that the Group was acquired by Bridgepoint from DPE Deutsche Private Equity and Maxburg Capital Partners for an undisclosed sum. Bridgepoint
Farmabios Breaks Ground to Expand its Manufacturing Footprint in Gropello Cairoli (Italy)
As part of an ongoing investment program to enhance PharmaZell Group’s production output, we have initiated the construction of a brand new large steroid building and a new warehouse on
Renewed GMP Certificate for our Manufacturing Facility Farmabios in Gropello Cairoli (Italy)
We are very glad to announce that the competent Italian authority (AIFA) has issued a renewed GMP certificate for our Farmabios SpA production facility [http://eudragmdp.ema.europa.eu/inspections/gmpc/generateGMPCPDF.do].
Farmabios expands its portfolio with Cannabidiol API
Global API supplier Farmabios announced today the addition of an ultra-pure synthetic Cannabidiol (CBD) drug substance to its portfolio. With an EU Drug Master File and cGMP manufacturing capacities, Farmabios
Career
We supply the world with active pharmaceutical ingredients – made possible by our committed employees.
If you’re looking for new challenges and a work environment that is driven by a collaborative culture and committed employees, consider a career with Farmabios. We offer competitive wages, job security and career advancement to develop your talent and skillset. You’ll have the opportunity to pursue ambitious objectives with the support of experienced teams and accessible management.
Flexibility is a key aspect to our success in the ever demanding pharmaceutical industry. We’re looking for people who thrive in a lean environment, with a clear vision and strategy. We believe in transparency and open dialogue – it enables us to work more efficiently.
We are an equal opportunity employer and we value diversity. We are committed to providing an inclusive environment of mutual respect where opportunity is available to all applicants, regardless of race, religion or philosophy of live.
Contact
